Security Risk Assessment Checklist for Clinical Trial Imaging Core Labs

Use this security risk assessment checklist to evaluate and strengthen protections across your imaging core lab. It focuses on Vulnerability Assessment, Data Integrity, access controls, and regulatory obligations unique to clinical trial imaging workflows.

Identification of Vulnerabilities

Start by mapping what you must protect: systems, people, data flows, and third parties. A structured Vulnerability Assessment ensures you see the full attack surface before prioritizing fixes.

• Inventory assets and data:
  • Catalog PACS/VNA, image upload portals, readers’ workstations, QC/annotation tools, databases, file shares, and backup targets.
  • Trace DICOM paths end to end: acquisition sites → transfer → receipt/triage → de-identification → storage → reads → exports.
  • List PHI/PII locations, linkage tables, and research identifiers used for blinding.
• Assess application and infrastructure exposure:
  • Check portals, APIs, and SFTP endpoints for outdated protocols, weak ciphers, default accounts, and missing rate limits.
  • Review PACS/viewers and plug-ins for unpatched CVEs and insecure temp file handling.
  • Examine cloud buckets, object storage, and snapshots for public access or overly broad IAM policies.
• Evaluate data-specific weaknesses:
  • Confirm de-identification removes PHI in headers and pixel data; detect burned-in text and private tags.
  • Validate checksum/fixity on ingest; flag corrupted or malformed DICOM objects.
  • Review export routines to prevent re-identification or unblinding.
• People and process risks:
  • Look for credential sharing among readers and technologists; verify least-privilege Role-Based Access Control.
  • Check joiner/mover/leaver offboarding; remove dormant and test accounts.
  • Assess security awareness around phishing and removable media.
• Third-party and supply chain:
  • Catalog CROs, cloud/SaaS tools, ePRO/EDC integrations, and teleradiology partners.
  • Verify security terms, BAAs/DUAs, incident commitments, and data return/Deletion clauses.
• Physical and environmental:
  • Secure server rooms, reader bays, and media handling; log visitors and deliveries.
  • Harden remote access for home-reading setups and mobile devices.

Analysis of Potential Impacts

Quantify how each vulnerability could affect confidentiality, availability, scientific validity, and Data Integrity. Use a consistent scale for likelihood and impact to drive prioritization.

• Privacy and compliance:
  • Unauthorized disclosure of PHI from misconfigured portals or incomplete de-identification.
  • Regulatory notifications, fines, and sponsor/IRB escalation following a breach.
• Data Integrity and scientific risk:
  • Tampered images, altered timestamps, or mismatched subject IDs causing unblinding or endpoint bias.
  • Loss of audit trail or version history undermining traceability and reproducibility.
• Operational and financial impact:
  • Ransomware or outages delaying reads, milestones, and database locks.
  • Costly re-reads/rescans, extended timelines, and reputational damage.
• Risk scoring method:
  • Rate likelihood (1–5) × impact (1–5) to produce a risk score; document rationale and owners.
  • Define acceptance thresholds and a treatment plan (mitigate, transfer, accept, avoid).

Implementation of Risk Mitigation Strategies

Apply layered controls that directly reduce prioritized risks. Combine technical safeguards, procedural discipline, and targeted training, and formalize Incident Response Planning for rapid containment.

• Technical safeguards:
  • Encrypt in transit (TLS 1.2/1.3, SFTP, VPN, DICOM over TLS) and at rest (AES-256 for databases, volumes, and object storage).
  • Harden endpoints with EDR, disk encryption, removal of local admin, and automated patching.
  • Segment networks; restrict east–west traffic; implement firewalls/WAF and secure bastions for admin access.
  • Adopt secure SDLC, dependency scanning/SBOM, secret management, and periodic penetration tests.
  • Implement integrity controls: checksums on ingest, immutable logs, and tamper-evident audit trails.
  • Backups with immutability and offline copies; test restores to meet RPO/RTO targets.
  • Automate de-identification with pixel text detection and validation; protect re-identification keys separately.
• Administrative controls:
  • Maintain SOPs for intake, de-identification, reads, exports, incident handling, and access reviews.
  • Vendor risk management with due diligence, security addenda, and periodic attestations.
  • Change control and validation for systems affecting Data Integrity and e-records.
  • Incident Response Planning: define roles, on-call rotations, playbooks (e.g., ransomware, credential compromise), and tabletop exercises.
• Physical controls:
  • Badge-controlled rooms, locked racks, camera coverage, and media chain-of-custody procedures.

Regulatory Compliance Requirements

Align your controls with core obligations for clinical research data. Prioritize HIPAA Compliance for PHI and FDA 21 CFR Part 11 for electronic records and signatures.

• HIPAA Compliance checklist:
  • Documented risk analysis and risk management program with periodic reviews.
  • Access controls, unique IDs, emergency access, and automatic logoff.
  • Audit controls capturing who accessed what, when, and from where.
  • Integrity controls to protect against improper alteration or destruction.
  • Transmission security for PHI and signed BAAs with covered entities and business associates.
• FDA 21 CFR Part 11 checklist:
  • System validation with traceable URS/IQ/OQ/PQ and documented test evidence.
  • Secure, computer-generated, time-stamped audit trails for create/modify/delete activities.
  • Controlled user accounts, Role-Based Access Control, and Multi-Factor Authentication for identity assurance.
  • Electronic signatures linked to records with certification and intent statements.
  • Record retention, accurate copies, backup/recovery, and change control.
• Governance and agreements:
  • Data use/transfer agreements defining purpose, retention, return/destruction, and breach duties.
  • Training records evidencing staff competence on SOPs and system use.

Enforcement of Access Control Measures

Design identity and access management around least privilege. Implement Role-Based Access Control and require Multi-Factor Authentication for all privileged and PHI-bearing access paths.

• RBAC design and duties segregation:
  • Define standard roles (site uploader, QC specialist, reader, adjudicator, data manager, system admin).
  • Separate administrative, read, and export permissions; prevent self-approval and unblinding.
• Authentication and session security:
  • Enforce Multi-Factor Authentication (prefer hardware keys or authenticator apps); document exceptions with compensating controls.
  • Adopt SSO/IdP with conditional access, device trust, and adaptive risk policies.
  • Set session timeouts, re-auth for PHI exports, and lockouts after failed attempts.
• Privileged access and service accounts:
  • Use PAM/jump hosts, just-in-time elevation, and recorded admin sessions.
  • Eliminate shared accounts; rotate secrets; restrict API keys by scope and IP.
• Access lifecycle and reviews:
  • Automate provisioning/deprovisioning; promptly revoke on role change or departure.
  • Perform periodic access reviews (at least quarterly; monthly for high-risk roles) with documented approvals.

Documentation and Reporting Practices

Strong documentation proves control effectiveness and speeds audits. Keep evidence organized within your QMS and maintain a living risk register tied to remediation plans.

• Risk and control documentation:
  • Risk register entries with description, score, owner, treatment, due date, and status.
  • Control inventory mapped to risks, HIPAA, and FDA 21 CFR Part 11 requirements.
• SOPs, training, and validation:
  • Current SOPs for intake, de-identification, reads, exports, incident handling, and access reviews.
  • Training completions and competency checks; periodic refreshers for high-risk roles.
  • Validation packages for regulated systems, including change control and regression tests.
• Incident and audit reporting:
  • Incident logs with timelines, containment steps, root cause, and CAPA tracking.
  • Internal audits and mock inspections; management review of KPIs and residual risk.
  • Sponsor-facing security reports summarizing posture, events, and improvements.

Evaluation of Data Protection Measures

Test whether protections work as designed and measurably uphold confidentiality and Data Integrity throughout the imaging lifecycle.

• Encryption effectiveness:
  • Verify TLS settings with scans; enforce modern cipher suites and certificate pinning where feasible.
  • Confirm at-rest encryption on databases, volumes, and object storage; monitor for plaintext drift.
• Key and secret management:
  • Store keys in HSM/KMS; rotate routinely; separate duties for key custody and usage.
  • Use short-lived credentials and vault-based secret retrieval with audit trails.
• Integrity controls:
  • Run fixity checksums on ingest and on schedule; reconcile anomalies.
  • Digitally sign critical exports; verify DICOM tag consistency and protocol conformance.
• Backup and recovery readiness:
  • Follow 3-2-1 with immutable/WORM copies; perform periodic restore drills and document RPO/RTO results.
  • Protect backups with RBAC and MFA; segregate backup networks and credentials.
• Data lifecycle governance:
  • Apply retention schedules; execute secure deletion and cryptographic erasure for retired data.
  • Control re-identification keys with separate storage, access approvals, and audit logging.
• Monitoring and metrics:
  • Implement DLP and anomaly detection on image repositories and export paths.
  • Track KPIs: time-to-revoke, patch latency, IR mean time to detect/contain, failed MFA rates, restore success.

Together, these measures form a Security Risk Assessment Checklist for Clinical Trial Imaging Core Labs that helps you identify exposures early, protect PHI, preserve scientific validity, and meet HIPAA Compliance and FDA 21 CFR Part 11 expectations.

FAQs.

What are the main security risks in clinical trial imaging core labs?

Top risks include incomplete de-identification, misconfigured upload portals or cloud storage, weak access controls, unpatched PACS/viewers, credential phishing, ransomware, insecure remote reading setups, and third-party gaps. Each can lead to PHI exposure, downtime, or compromised Data Integrity that jeopardizes endpoints and timelines.

How do access controls protect patient data?

Role-Based Access Control limits each user to the minimum functions and datasets needed, while Multi-Factor Authentication prevents account takeovers. Combined with SSO, session timeouts, and periodic access reviews, these controls reduce unauthorized disclosure and protect the audit trail that proves who accessed which records and why.

What regulatory standards apply to imaging core labs?

In the United States, HIPAA governs safeguards for PHI, and FDA 21 CFR Part 11 sets expectations for validated systems, audit trails, and electronic signatures used in regulated records. Your SOPs, training, and system validation should map directly to these requirements and to sponsor or institutional policies.

How is a risk assessment checklist maintained and updated?

Treat it as a living artifact: review at least annually and after major changes, incidents, new sites, or new tools. Update the risk register, reprioritize based on likelihood and impact, verify controls via testing, and track remediation with owners and due dates. Share results in management reviews and sponsor reports to demonstrate continuous improvement.